Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

André Bergman

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Cultured Tumor Cells

Physiology

Disorders

Phenomena

Drug Synergism

Procedures

Living Beings

Mice

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
29
Peters, Godefridus
16
Veerman, Gijsbert
13
PINEDO, HERBERT
10
Van Moorsel, Catharina
10
Kuiper, CM
9
Ruiz van Haperen, Veronique
6
Smid, Kees
6
Voorn, Daphne
4
Van der Wilt, Clasina
4
Kroep, Judith
3
Eriksson, S
3
Hendriks, HR
3
Vermorken, Jan
3
Sandvold, ML
3
Myhren, F

Sign-in to see all Coauthors

Publications

TOP 3
Sigmond J; Honeywell R J; Postma T J; Dirven C M F; de Lange S M; van der Born K; Laan A C; Baayen J C A; Van Groeningen C J; Bergman A M; Giaccone G; Peters G J
Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer.
Sigmond J; Kamphuis J A E; Laan A C; Hoebe E K; Bergman A M; Peters G J
The synergistic interaction of gemcitabine and cytosine arabinoside with the ribonucleotide reductase inhibitor triapine is schedule dependent.
Smid K; Bergman A M; Eijk P P; Veerman G; van Haperen V W T Ruiz; van den Ijssel P; Ylstra B; Peters G J
Micro-array analysis of resistance for gemcitabine results in increased expression of ribonucleotide reductase subunits.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of André Bergman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Sigmond J; Honeywell R J; Postma T J; Dirven C M F; de Lange S M; van der Born K; Laan A C; Baayen J C A; Van Groeningen C J; Bergman A M; Giaccone G; Peters G J
Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(1):182-7.
2007: Sigmond J; Kamphuis J A E; Laan A C; Hoebe E K; Bergman A M; Peters G J
The synergistic interaction of gemcitabine and cytosine arabinoside with the ribonucleotide reductase inhibitor triapine is schedule dependent.
Biochemical pharmacology 2007;73(10):1548-57.
2006: Smid K; Bergman A M; Eijk P P; Veerman G; van Haperen V W T Ruiz; van den Ijssel P; Ylstra B; Peters G J
Micro-array analysis of resistance for gemcitabine results in increased expression of ribonucleotide reductase subunits.
Nucleosides, nucleotides & nucleic acids 2006;25(9-11):1001-7.
2005: van de Wiel Mark A; Costa Jose L; Smid Kees; Oudejans Cees B M; Bergman Andries M; Meijer Gerrit A; Peters Godefridus J; Ylstra Bauke
Expression microarray analysis and oligo array comparative genomic hybridization of acquired gemcitabine resistance in mouse colon reveals selection for chromosomal aberrations.
Cancer research 2005;65(22):10208-13.
2005: Bergman Andries M; Eijk Paul P; Ruiz van Haperen Veronique W T; Smid Kees; Veerman Gijsbert; Hubeek Isabelle; van den Ijssel Paul; Ylstra Bauke; Peters Godefridus J
In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant.
Cancer research 2005;65(20):9510-6.
2004: Bergman A M; Kuiper C M; Myhren F; Sandvold M L; Hendriks H R; Peters G J
Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinosylcytosine (ara-C) in leukemia and solid tumor cell lines.
Nucleosides, nucleotides & nucleic acids 2004;23(8-9):1523-6.
2004: Bergman A M; Kuiper C M; Noordhuis P; Smid K; Voorn D A; Comijn E M; Myhren F; Sandvold M L; Hendriks H R; Fodstad O; Breistøl K; Peters G J
Antiproliferative activity and mechanism of action of fatty acid derivatives of gemcitabine in leukemia and solid tumor cell lines and in human xenografts.
Nucleosides, nucleotides & nucleic acids 2004;23(8-9):1329-33.
2004: Bergman A M; Kuiper C M; Voorn D A; Comijn E M; Myhren F; Sandvold M L; Hendriks H R; Peters G J
Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.
Biochemical pharmacology 2004;67(3):503-11.
2003: Bergman A M; Pinedo H M; Talianidis I; Veerman G; Loves W J P; van der Wilt C L; Peters G J
Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines.
British journal of cancer 2003;88(12):1963-70.
2003: Van Moorsel C J A; Smid K; Voorn D A; Bergman A M; Pinedo H M; Peters G J
Effect of gemcitabine and cis-platinum combinations on ribonucleotide and deoxyribonucleotide pools in ovarian cancer cell lines.
International journal of oncology 2003;22(1):201-7.
2002: Bergman Andries M; Pinedo Herbert M; Peters Godefridus J
Determinants of resistance to 2',2'-difluorodeoxycytidine (gemcitabine).
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2002;5(1):19-33.
2001: Bergman A M; Munch-Petersen B; Jensen P B; Sehested M; Veerman G; Voorn D A; Smid K; Pinedo H M; Peters G J
Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines.
Biochemical pharmacology 2001;61(11):1401-8.
2001: Bergman A M; Pinedo H M; Peters G J
Steroids affect collateral sensitivity to gemcitabine of multidrug-resistant human lung cancer cells.
European journal of pharmacology 2001;416(1-2):19-24.
2000: Bergman A M; Giaccone G; van Moorsel C J; Mauritz R; Noordhuis P; Pinedo H M; Peters G J
Cross-resistance in the 2',2'-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugs.
European journal of cancer (Oxford, England : 1990) 2000;36(15):1974-83.
2000: Peters G J; van der Wilt C L; van Moorsel C J; Kroep J R; Bergman A M; Ackland S P
Basis for effective combination cancer chemotherapy with antimetabolites.
Pharmacology & therapeutics 2000;87(2-3):227-53.
2000: van Moorsel C J; Bergman A M; Veerman G; Voorn D A; Ruiz van Haperen V W; Kroep J R; Pinedo H M; Peters G J
Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines.
Biochimica et biophysica acta 2000;1474(1):5-12.
2000: van der Wilt C L; Kroep J R; Bergman A M; Loves W J; Alvarez E; Talianidis I; Eriksson S; van Groeningen C J; Pinedo H M; Peters G J
The role of deoxycytidine kinase in gemcitabine cytotoxicity.
Advances in experimental medicine and biology 2000;486():287-90.
1999: Padrón J M; van Moorsel C J; Bergman A M; Smitskamp-Wilms E; van der Wilt C L; Peters G J
Selective cell kill of the combination of gemcitabine and cisplatin in multilayered postconfluent tumor cell cultures.
Anti-cancer drugs 1999;10(5):445-52.
1999: van Moorsel C J; Pinedo H M; Veerman G; Bergman A M; Kuiper C M; Vermorken J B; van der Vijgh W J; Peters G J
Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines.
British journal of cancer 1999;80(7):981-90.
1999: Bergman A M; Cristalli G; Vittori S; Wang J; Eriksson S; Peters G J
Biological activity of 1-deazapurine nucleosides: role of deoxycytidine kinase?
Nucleosides & nucleotides 1999;18(4-5):897-8.
1999: Bergman A M; Pinedo H M; Jongsma A P; Brouwer M; Ruiz van Haperen V W; Veerman G; Leyva A; Eriksson S; Peters G J
Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase.
Biochemical pharmacology 1999;57(4):397-406.
1998: van Moorsel C J; Veerman G; Ruiz van Haperen V W; Bergman A M; Jensen P B; Sehested M; Peters G J
Differential effects of gemcitabine on nucleotide pools of 19 solid tumor cell lines.
Advances in experimental medicine and biology 1998;431():661-5.
1998: Bergman A M; Pinedo H M; Veerman G; Kuiper C M; Peters G J
Increased sensitivity to gemcitabine of P-gP and MRP overexpressing human non-small cell lung cancer cell lines.
Advances in experimental medicine and biology 1998;431():591-4.
1998: Bergman A M; Pinedo H M; Ruiz van Haperen V W; Veerman G; Kuiper C M; Peters G J
Cross-resistance of the gemcitabine resistant human ovarian cancer cell line AG6000 to standard and investigational drugs.
Advances in experimental medicine and biology 1998;431():587-90.
1998: van Moorsel C J; Veerman G; Vermorken J B; Voorn D A; Kroep J R; Bergman A M; Pinedo H M; Peters G J
Mechanisms of synergism between gemcitabine and cisplatin.
Advances in experimental medicine and biology 1998;431():581-5.
1997: Holland S K; Bergman A M; Zhao Y; Adams E R; Pizzorno G
19F NMR monitoring of in vivo tumor metabolism after biochemical modulation of 5-fluorouracil by the uridine phosphorylase inhibitor 5-benzylacyclouridine.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 1997;38(6):907-16.
1997: van Moorsel C J; Veerman G; Bergman A M; Guechev A; Vermorken J B; Postmus P E; Peters G J
Combination chemotherapy studies with gemcitabine.
Seminars in oncology 1997;24(2 Suppl 7):S7-17-S7-23.
1996: Peters G J; Ruiz van Haperen V W; Bergman A M; Veerman G; Smitskamp-Wilms E; van Moorsel C J; Kuiper C M; Braakhuis B J
Preclinical combination therapy with gemcitabine and mechanisms of resistance.
Seminars in oncology 1996;23(5 Suppl 10):16-24.
1996: Bergman A M; Ruiz van Haperen V W; Veerman G; Kuiper C M; Peters G J
Synergistic interaction between cisplatin and gemcitabine in vitro.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(3):521-30.
1995: Peters G J; Bergman A M; Ruiz van Haperen V W; Veerman G; Kuiper C M; Braakhuis B J
Interaction between cisplatin and gemcitabine in vitro and in vivo.
Seminars in oncology 1995;22(4 Suppl 11):72-9.
1994: Bergman A M; Ruiz van Haperen V W; Veerman G; Kuiper C M; Peters G J
Synergistic interaction between cisplatin and gemcitabine in ovarian and colon cancer cell lines.
Advances in experimental medicine and biology 1994;370():139-43.

Sign-in to see more